Literature DB >> 31514987

Determination of five neurotransmitters in the rat brain for the study of the hypnotic effects of Ziziphi Spinosae Semen aqueous extract on insomnia rat model by UPLC-MS/MS.

Yan Yan1, Qiang Li1, Hui-Zhi DU1, Chen-Xi Shen1, Ai-Ping Li1, Xiang-Ping Pei2, Chen-Hui DU3, Xue-Mei Qin4.   

Abstract

Ziziphi Spinosae Semen (ZSS) has been used for treatment of insomnia in China for centuries. To reveal the influence of insomnia on the levels of the neurotransmitters including serotonin (5-HT), glutamic acid (Glu), γ-aminobutyric acid (GABA), noradrenaline (NE) and dopamine (DA), and to study the role of ZSS aqueous extract in the treatment of insomnia, an UPLC-ESI- MS/MS method was developed and validated for simultaneous determination of five neurotransmitters in the rat brain. The brain samples were pretreated by one-step direct protein precipitation with acetonitrile. The analytes were detected in positive mode with multiple reaction monitoring (MRM) and the procedure was completed in less than 10 min. The method showed a good linearity (R2 > 0.9967) with the other validation parameters were within acceptance range. The results indicated that the concentration of 5-HT, GABA and DA is significantly lower (P < 0.01) in para-chlorophenylalanine (PCPA)-induced insomnia rat model group, while Glu and NE significantly higher than those in control group (P < 0.01). Treatment with ZSS aqueous extract (4 or 8 g·kg-1·d-1 for seven days) could ameliorate the symptoms of insomnia by significantly changing the levels of the neurotransmitter parameters mentioned above. The data obtained in this study demonstrate that ZSS aqueous extract could ameliorate the symptoms of insomnia by modulating the levels of monoamines and amino acid neurotransmitters in the brain.
Copyright © 2019 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypnotic effects; Neurotransmitters; UPLC-MS/MS; Ziziphi Spinosae Semen

Mesh:

Substances:

Year:  2019        PMID: 31514987     DOI: 10.1016/S1875-5364(19)30077-9

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  6 in total

1.  Comprehensive 16S rDNA Sequencing and LC-MS/MS-Based Metabolomics to Investigate Intestinal Flora and Metabolic Profiles of the Serum, Hypothalamus and Hippocampus in p‑Chlorophenylalanine-Induced Insomnia Rats Treated with Lilium brownie.

Authors:  Yanpo Si; Xiaohui Chen; Tao Guo; Wenjun Wei; Lili Wang; Fei Zhang; Xiaoya Sun; Mengqi Liu
Journal:  Neurochem Res       Date:  2021-10-18       Impact factor: 3.996

2.  Disruption of Glutamate Homeostasis in the Brain of Rat Offspring Induced by Prenatal and Early Postnatal Exposure to Maternal High-Sugar Diet.

Authors:  Jozef Mizera; Bartosz Pomierny; Anna Sadakierska-Chudy; Beata Bystrowska; Lucyna Pomierny-Chamiolo
Journal:  Nutrients       Date:  2022-05-24       Impact factor: 6.706

3.  Nyctinastic herbs decoction improves para-chlorophenylalanine-induced insomnia by regulating the expression level of neurotransmitters.

Authors:  Yiwen Yang; You Wu; Peiqin Xu; Fan Guo; Fei Guo; Baican Yang
Journal:  Ann Transl Med       Date:  2021-10

Review 4.  The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.

Authors:  Xuedong An; Liyun Duan; Yue Hong Zhang; Shenghui Zhao; Rong Rong Zhou; Yingying Duan; Fengmei Lian; Xiaolin Tong
Journal:  Chin Med       Date:  2021-06-07       Impact factor: 5.455

5.  Lilium davidii extract alleviates p‑chlorophenylalanine‑induced insomnia in rats through modification of the hypothalamic-related neurotransmitters, melatonin and homeostasis of the hypothalamic-pituitary-adrenal axis.

Authors:  Yanpo Si; Lili Wang; Jinxu Lan; Hanwei Li; Tao Guo; Xiaohui Chen; Chunhong Dong; Zhen Ouyang; Sui-Qing Chen
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

6.  Efficacy of the Jingxin Zhidong Formula for Tic Disorders: A Randomized, Double Blind, Double Dummy, Parallel Controlled Trial.

Authors:  Fei Fan; Long Hao; Si Zhang; Ying Zhang; Zhaoxiang Bian; Xuan Zhang; Qiong Wang; Fei Han
Journal:  Neuropsychiatr Dis Treat       Date:  2022-01-11       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.